Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$46,520,192
+$15,382,692 QoQ
Shares Held
183,172
+43.8% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#463
of 4,676 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $1,720,661,138 across 10 Drug Manufacturers - General names. JNJ ranks #7 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
7,995,711 | $460,712,867 | |
| 2 | PFE |
Pfizer Inc
|
16,793,903 | $404,397,184 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
3,110,000 | $392,917,400 | |
| 4 | BIIB |
Biogen Inc.
|
1,122,981 | $242,631,274 | |
| 5 | LLY |
ELI LILLY & Co
|
59,898 | $71,843,464 | |
| 6 | ABBV |
AbbVie Inc.
|
201,334 | $50,663,687 | |
| 7 | JNJ |
Johnson & Johnson
This page
|
183,172 | $46,520,192 | |
| 8 | AMGN |
Amgen Inc
|
74,159 | $26,854,457 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $46,520,192 | 183,172 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $31,137,500 | 127,383 | Shares | Sole | 2026-06-18 | |
| 2025-12-31 | $40,451,895 | 195,467 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $91,812,752 | 495,161 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $477,687,895 | 3,127,253 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $502,509,130 | 3,030,084 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $29,568,715 | 204,458 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $43,057,397 | 265,688 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $35,166,826 | 240,605 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $33,013,778 | 208,697 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $28,787,338 | 183,663 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $24,484,211 | 157,202 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $27,342,579 | 165,192 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $25,001,655 | 161,301 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $16,156,232 | 91,459 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,652,549 | 10,116 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $11,812,580 | 66,546 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $24,347,680 | 137,379 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $23,882,056 | 139,604 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $25,865,032 | 160,155 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $24,841,144 | 150,790 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $23,988,854 | 145,962 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $24,995,878 | 158,825 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $28,688,580 | 192,696 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $31,634,296 | 224,947 | Shares | Sole | 2020-07-29 | |
| No filing history on record for this holder in this stock. | ||||||